Novel viral expression system
The novel expression system enables a likewise rapid and effective in vivo production of hybrid VLPs that carry antigenic determinants of a particular pathogen within their viral capsid. The recombinant VLPs are replication incompetent, non-infectious and produced in a host (S. cerevisiae) that possesses GRAS status.
Further Information: PDF
Universität des Saarlandes Wissens- und Technologietransfer GmbH PatentVerwertungsAgentur der saarländischen Hochschulen
Phone: +49 (0)681/302-6340
Contact
Dr. Annekathrin Seifert (Dipl.-Chem.), Dipl.-Kfm. Axel Koch (MBA), Dr. Hauke Studier (Dipl.-Phys.)
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Economies take off with new airports
A global study by an SUTD researcher in collaboration with scientists from Japan explores the economic benefits of airport investment in emerging economies using nighttime satellite imagery. Be it for…
CAR T–cell immunotherapy targets
Pan-cancer analysis uncovers a new class of promising CAR T–cell immunotherapy targets. Scientists at St. Jude Children’s Research Hospital found 156 potential CAR targets across the brain and solid tumors,…
Stony coral tissue loss disease
… is shifting the ecological balance of Caribbean reefs. The outbreak of a deadly disease called stony coral tissue loss disease is destroying susceptible species of coral in the Caribbean…
